|Year : 2020 | Volume
| Issue : 2 | Page : 194-198
In vitro antioxidant and antidiabetic activities of leaf and flower extracts from Bombax ceiba
Nurarat Kriintong, Teeraporn Katisart
Department of Biology, Faculty of Science, Mahasarakham University, Kantharawichai, Maha Sarakham, Thailand
|Date of Web Publication||18-May-2020|
Dr. Teeraporn Katisart
Department of Biology, Faculty of Science, Mahasarakham University, Talat, Maha Sarakham, 44150
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Context: Bombax ceiba is belonging to the family Bombacaceae. Dried stamen of this plant is used as vegetable and food ingredients for people in the Northern part of Thailand. There are very few reports on the biological activities in this plant, especially the flower parts. Objectives: The present study aimed to demonstrate the phytochemical screening and in vitro antioxidant and antidiabetic activities of crude extracts from B. ceiba. Materials and Methods: The leaf and flower part of B. ceiba were extracted using different solvents including water, 50% ethanol, and 95% ethanol. The phytochemical constituents were determined using standard qualitative methods. Total phenolic content (TPC) and total flavonoid content (TFC) were analyzed by colorimetric methods. 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay, 2,2-azino-bis-(3-ethylbenzothaizoline-6-sulphonate (ABTS) assay, and ferric reducing antioxidant power (FRAP) assay were used to investigate the in vitro antioxidant and antidiabetic activities of the extracts. For in vitro antidiabetic activities, α-glucosidase and α-amylase inhibitory effects were tested. Results: Phytochemical screening indicated the presence of alkaloids, flavonoids, coumarins, saponins, tannins, terpenoids, and cardiac glycosides in this plant. The highest TPC and TFC were found in 95% ethanol flower extract (2.73 ± 0.064 mg gallic acid equivalent/g and 28.25 ± 2.33 mg quercetin equivalent/g, respectively.). However, the highest antioxidant activity (DPPH and ABTS + assay) was found in 95% ethanol leaf extract (0.012 ± 0.0003, 0.009 ± 0.0005 mg/mL, respectively.) and FRAP assay was found in 95% ethanol flower extract (349.27 ± 35.16 mg trolox equivalent/g). The highest α-glucosidase and α-amylase inhibitory activities were found in 95% ethanol flower extract (0.001 ± 0.0012 and 0.0002 ± 0.0001 mg/mL, respectively). Conclusion: The crude extracts from B. ceiba showed the potent in vitro antioxidant and antidiabetic activities, especially the flower extracts. These findings confirm the ethnobotanical uses of B. ceiba as food and medicinal plants. Further studies on biological and pharmacological activities of this plant in the animal model and clinical trials must be carried out to confirm the use in medical aspects.
Keywords: Bombax ceiba leaf and flower extracts, in vitro antidiabetic inhibitory activity, in vitro antioxidant activity, phytochemical screening
|How to cite this article:|
Kriintong N, Katisart T. In vitro antioxidant and antidiabetic activities of leaf and flower extracts from Bombax ceiba. Phcog Res 2020;12:194-8
|How to cite this URL:|
Kriintong N, Katisart T. In vitro antioxidant and antidiabetic activities of leaf and flower extracts from Bombax ceiba. Phcog Res [serial online] 2020 [cited 2020 May 27];12:194-8. Available from: http://www.phcogres.com/text.asp?2020/12/2/194/284416
- Phytochemical constituents revealed the presence of alkaloids, flavonoids, coumarins, saponins, tannins, terpenoids, and cardiac glycosides in Bombax ceiba extracts. The highest total phenolic content and total flavonoid content were found in 95% ethanol flower extract. The highest antioxidant activity (2,2-diphenyl-1-picrylhydrazyl and 2,2-azinobis-(3-ethylbenzothaizoline-6-sulphonate + assay) was found in 95% ethanol leaf extract and ferric reducing antioxidant power assay was found 95% ethanol flower extract. The highest a-glucosidase and a-amylase inhibitory activities were found in 95% ethanol flower extract. The crude extracts from B. ceiba showed the potent in vitro antioxidant and antidiabetic activities, especially the flower extracts. These findings confirm the ethnobotanical uses of B. ceiba as food and medicinal plants. Further studies on biological and pharmacological activities of this plant in the animal model and clinical trials must be carried out to confirm the use of this plant in medical aspects.
Abbreviations used: ALE: Aqueous leaf extract; AFE: Aqueous flower extract; HELE: 50% ethanol leaf extract; HEFE: 50% ethanol flower extract; ELE: 95% ethanol leaf extract; EFE: 95% ethanol flower extract; DPPH: 2,2-diphenyl-1-picrylhydrazyl; ABTS: 2,2-azino-bis-(3-ethylbenzothaizoline-6-sulphonate; FRAP: Ferric reducing antioxidant power; TPC: Total phenolic content; TFC: Total flavonoid content.
| Introduction|| |
Bombax ceiba (Bombacaceae), also known as Ngui (in Thai), is found and grown in Africa, Australia, and Asia including Thailand. The pharmacological studies in this plant provided the information that B. ceiba exhibits various biological activities such as astringent, cooling, stimulant, diuretic, aphrodisiac, demulcent, and tonic activities.
It was found that the young roots of B. ceiba have hypoglycemic, hypolipidemic, and hepatoprotective activities and confirm the traditional uses of this plant to manage diabetes and its associated liver toxicity. In addition, the male rat treated with young root extracts of this plant has improved sexual performances and behaviors.
The methanolic stem bark extract of this plant has excellent anti-obesity activity in rats induced by a high-fat diet. Bark and seeds powder has hyperlipidemic activity with a reduction in serum and tissue lipid profiles. The lupeol from stem bark exhibits the inhibitory effect on human umbilical venous endothelial cells (HUVEC) tube formation without affecting the growth of tumor cell lines. It is reported that there are triterpenoid compounds in the stem bark extract, which could be responsible for lowering blood glucose levels.
The leaf extracts displayed significant wound healing activity. They also showed a remarkable hypoglycemic and hypolipidemic activity which is related to Type 2 diabetes. Moreover, the antidiabetic activity of B. ceiba leaf extracts may due to the antioxidant activity and pancreatic β-cell histology improvement. The mangiferin in leaf extracts improved the diabetic complications in the kidney and decreased free radicals in meningeal cells. In addition, the leaf extracts exhibit the antianxiety activity. The leaf extracts of this plant improved the stress behaviors in animal models. The leaf extracts also increased the antioxidant values in brain tissues of rats.
It is reported that the flower extract has an excellent antioxidant activities. The methanolic flower extract of B. ceiba has the protective effects against cytotoxicity in the cell line. The flowers of this plant also could improve liver function in the animal model which may due to its antioxidant potential. The aqueous flower extract prevents against cardiotoxicity. The flower extracts possess a protective effect on the gastric injury. The flower extracts also showed the inhibitory effects on renal cancer cell lines. The biological activity of B. ceiba flower extracts may relate to the presence of ß-sitosterol and fatty acids. The aqueous methanol flower extract exhibits the hepatoprotective activity.
The fruit of B. ceiba possesses the lithotriptic activity confirming the use in the treatment of urolithiasis. The fruit extracts also have diuretic activity. The leaf and flower extracts of B. malabaricum which is a synonym of B. ceiba possess significant antipyretic and antioxidant activities, respectively.
The phytochemical screening revealed that flower extracts of this plant consist of three xanthones and nine flavonoids. Another study found that the flowers comprise ten flavonoids, quercetin, four coumarins, and seven other compounds.
For ethnobotanical uses, it was found that androecium of this plant is used as a food ingredient for Indian people. Some parts of this plant are edible that is famous in the Northern part Thailand. People use flowers to cook as curry soup, called“Nam Ngiao” served with rice noodles. However, there are a few scientific reports on the biological activities of leaf and flower of B. ceiba. Therefore, this study was carried out to study thein vitro antioxidant and antidiabetic activities of B. ceiba leaf and flower extracts.
| Materials and Methods|| |
Plant preparation and extraction
Leaf and flower parts of B. ceiba were used for extractions. They were collected from the cultivation area in Phichit Province, Northern part of Thailand. They were washed by running through tap water and then dried in a hot air oven at 40°C for 18 h. Then, they were ground as fine power using an electrical grinder. The aqueous extracts were prepared by added 100 g of dry powder of leaf and flower into 1000 mL of distilled water and boiled at 100°C 10 min for three times. The 50% and 95% ethanol extracts were prepared by adding 100 g of dry powder of leaf and flower in 400 mL of 50% and 95% ethanol and macerated for 7 days. The crude residues were filtered using filter paper Whatman No. 1. The filtrates were obtained by removing the solvents in a rotary evaporator and then freeze-dried as a fine powder and kept at −20°C until used.
The leaf and flower extracts of B. ceiba were screened for the presence of alkaloids, flavonoids, coumarins, anthraquinones, saponins, tannins, terpenoids, steroids, and cardiac glycosides. The experiment was performed using standard qualitative methods described by Wadood et al. with some modifications.
Determination of total phenolic content
The total phenolic content (TPC) was investigated by Folin Ciocalteu's method and described by Singleton et al. with some modifications. Briefly, 100 μL of the gallic acid solution (standard) and samples was prepared in a 10 mL test tube. Five hundred microliter of the Folin–Ciocalteu's reagent was added and mixed. One hundred microliter distilled water was used as a blank. After that, 400 μL of 7.5% Na2 CO3 solution was added in each tube and mixed well. The samples were left to react at 25°C for 30 min in the dark room. Ultraviolet–visible (UV-Vis) spectrophotometer was used to measure the absorbance at 765 nm. Five replications were performed in each treatment. The TPC value was expressed as mg gallic acid equivalents (GAE) per g sample.
Determination of total flavonoid content
The total flavonoid content (TFC) was investigated by a colorimetric method and described by Zhishen et al. with some modifications. One hundred microliter of the quercetin solution and samples was prepared in a 10 mL test tube. Four hundred micro liter of 2.5% NaNO2 was added and mixed. The blank used 100 μL distilled water instead of the standard solution and samples. Thereafter, 500 μL of 5% AlCl3 solution and 2000 μL of distilled water were added. The samples were allowed to react at 25°C for 10 min. The absorbance was measured using UV-Vis spectrophotometer at 415 nm. The experiments were repeated five times. The TFC value was expressed as mg quercetin equivalents (QEs) in per g sample.
Determination of in vitro antioxidant activity
2,2-diphenyl-1-picrylhydrazyl radical scavenging assay
2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay was carried out by the modified method described by Brand-Williams et al. One millimeter DPPH was dissolved in distilled water. One hundred microliter of the standard solution and samples was prepared. Nine hundred microliter of 1 mM DPPH solution was added and allowed to react for 30 min at 25°C. The absorbance was measured at 515 nm to determine the DPPH radical inhibitory activity of the extracts. The experiments were repeated five times. In the present study, the positive controls were ascorbic acid and trolox. The results were expressed as a percentage inhibition of DPPH calculated from the following formula.
% radical inhibition = ([A0− A1]/A0) ×100
Whereas, A0= Absorbance of blank, A1= Absorbance of sample
Half-maximal inhibitory concentration (IC50) was calculated from the calibration curve by linear regression.
2,2-azinobis-(3-ethylbenzothaizoline-6-sulphonate radical scavenging assay
The procedure described by Re et al. was followed. Seven millimeter of 2,2-azinobis-(3-ethylbenzothaizoline-6-sulphonate (ABTS) was dissolved in K2S2O8 solution with pH 7.4. The ABTS solution was left at 25°C for 16 h in the dark and then dilute ABTS solution by distilled water in ratio 1:50, respectively. Aliquots of 100 μL of the standard solution and samples were prepared in a 10 mL test tube and 900 μl of ABTS solution was added and allowed to react 25°C for 6 min. The ABTS inhibition was measured by the reduction in absorbance at 734 nm. The positive control was ascorbic acid and trolox, while distilled water was used as a negative control and as blank. IC50 was determined from the standard curve.
Ferric reducing antioxidant power radical scavenging assay
Ferric reducing antioxidant power (FRAP) assay was adapted from Benzie and Strain with some modifications. The FRAP reagent containing 2.5 mL of a 10 mM 2, 4, 6-tripyridy-s-triazine solution was prepared in 40 mM HCl plus 2.5 mL of 20 mM FeCl3 and 25 mL of 0.3 mM acetate buffer, pH 3.6. The reagent was prepared freshly and incubated at 37°C for 60 min. One hundred microliter of the standard solution and samples was prepared. 900 μL of FRAP solution was added and allowed to react 25°C for 5 min. The experiments were repeated five times. Trolox was used as a positive control. The absorbance was measured at 593 nm. The inhibition of a ferric-tripyridyltriazine value was expressed as mg trolox equivalents (TEs) per g sample.
Determination ofin vitro antidiabetic activities
α-Glucosidase inhibition assay
The ability of B. ceiba extract to inhibit α-glucosidase that was performed using the colorimetric methods was described in Dong et al.'s study with some modifications. One hundred microliter of the standard solution and samples was prepared. One hundred microliter of 1 unit/mL α-glucosidase in 0.1 M potassium phosphate buffer (pH 6.8) was prepared. After incubation at 37°C for 20 min, 100 μL of 2 mM pNP-G in the buffer was added; then, the solution was incubated at 37°C for 20 min. Three hundred and twenty microliter of 1 mM Na2 CO3 in the buffer was added to stop the reaction. The absorbance was measured at 405 nm. Acarbose was used as a positive control, while a 0.1 M potassium phosphate buffer was used as a negative control. IC50 was calculated from the standard curve. The results were expressed as percentage inhibition of α-glucosidase compared to the controls.
% inhibition = ([A0 − A1]/A0) ×100
Whereas, A0= Absorbance of blank, A1= Absorbance of sample
IC50 values were calculated with a standard curve plotted by inhibition percentage against the concentration.
α-Amylase inhibition assay
The α-amylase inhibition protocol was adapted from the method described by Akkarachaiyasit. α-Amylase was dissolved in sodium phosphate buffer pH 6.9 to adjust a concentration of 3 unit/mL solution. Rice starch (1% w/v) was dissolved in hot water. The α-amylase 150 μL, leaf and flower extract of B. ceiba or acarbose (standard) 20 μL, 180 μL of sodium phosphate buffer pH 6.9, and 150 μL of starch solution were added. The solution was incubated at 37°C for 10 min. Then, 1% 3,5-dinitrosalicylic acid (DNS) 500 μL was added. Thereafter, the solution was decocted for 10 min. Five hundred microliter sodium potassium tartrate was added. The inhibition of α-amylase activity was measured at a wavelength of 540 nm. Acarbose was used as a positive control and 0.1 M potassium phosphate buffer as a negative control and as blank. IC50 was determined from the standard curve.
All data were expressed as mean ± standard error of mean with n = 5. The difference among means was tested using one-way analysis of variance followed by Duncan multiple range test. P < 0.05 was considered statistically significance. Statistical analysis was carried out using SPSS Statistics version 23.0 (IBM; New Orchard Road, Armonk, New York, United States).
| Results|| |
Qualitative phytochemical screening of leaf and flower extract of B. ceiba demonstrated that the extracts contain alkaloids, flavonoids, glycosides, and coumarins. However, there are no anthraquinone and steroid in this plant [Table 1].
|Table 1: Phytochemical constituent's different solvent of Bombax ceiba extracts|
Click here to view
Total phenolic and flavonoid content
EFE of B. ceiba obviously showed the highest TPC and TFC (2.73 ± 0.064 mg GAE/g, 28.25 ± 2.33 mg QE/g, respectively), while ALE showed the lowest TPC and TFC (0.09 ± 0.002 mg GAE/g, 1.34 ± 0.09 mg QE/g, respectively) compared with other extracts [Table 2].
|Table 2: Total phenolic content and total flavonoid content of Bombax ceiba extracts|
Click here to view
In vitro antioxidant activities
2,2-diphenyl-1-picrylhydrazyl radical scavenging activity
The DPPH radical scavenging activities of B. ceiba (IC50 values) are shown in [Table 3]. It was found that both leaf extracts (95% ethanol leaf extract [ELE]) (IC50 =0.012 ± 0.0003 mg/mL) and flower extracts (50% ethanol flower extract [HEFE]) (IC50 =0.019 ± 0.0002 mg/mL) exhibited strong radical scavenging activity compared to those of the standard trolox (IC50 =0.016 ± 0.0011 mg/mL). However, the extracts had the less potent antioxidant activity than those of the standard ascorbic acid (IC50 =0.004 ± 0.0002 mg/mL).
2,2-azinobis-(3-ethylbenzothaizoline-6-sulphonate radical scavenging activity
The result indicated that the plants extracts inhibited the ABTS + radicals; the lowest IC50 values were found in ELE (0.009 ± 0.0005 mg/mL), while highest IC50 values were found in AFE (0.197 ± 0.0011 mg/mL), as shown in [Table 3]. However IC50 values of ELE were almost similar to those of the standard trolox (0.009 ± 0.0006 mg/mL).
Ferric reducing antioxidant power radical scavenging activity
The reducing power of the extracts of different solutions is shown in [Table 3]. EFE obviously showed the highest ability to reduce Fe+ (349.27 ± 35.16 mg TE/g), while ALE (30.04 ± 0.64 mg TE/g) showed the lowest compared to other extracts (P < 0.05).
In vitro antidiabetic activities
α-Glucosidase inhibitory activity
The IC50 values of α-glucosidase inhibition of EFE, AFE, and HEFE were 0.001 ± 0.0012, 0.002 ± 0.0006, and 0.003 ± 0.0004 mg/mL, respectively. The high IC50 values of α-glucosidase inhibition of HELE, ALE, and ELE of B. ceiba leaves were 0.121 ± 0.0022, 0.175 ± 0.0027, and 0.187 ± 0.0089 mg/mL, respectively, as shown in [Table 4].
|Table 4: α-Glucosidase and a-amylase inhibitory activities of Bombax ceiba extracts|
Click here to view
α-Amylase inhibitory activity
In this study, the IC50 value of α-amylase inhibition of EFE was 0.0002 ± 0.0001 mg/mL followed by ELE (0.0012 ± 0.0009 mg/mL) and HEFE (0.0024 ± 0.0002 mg/mL), as shown in [Table 4].
| Discussion|| |
B. ceiba extracts possess various biological activities such as antioxidant, anti-inflammatory, and antimicrobial activities. In addition, the extracts from this plant exhibit their medicinal values in the treatment of diabetes and hyperglycemia. Flower parts of B. ceiba have been used as a food ingredient among Thai people. However, there are a few scientific reports on their biological and pharmacological activities. In this present study, it was found that leaf and flower extracts of B. ceiba contain phytochemicals including alkaloids, flavonoids, coumarins, saponins, tannins, terpenoids, and cardiac glycosides. Moreover, the high total phenolic and flavonoid contents were found in flower extracts. The flower extracts also exhibit the high antioxidant and antidiabetic activities in vitro. It was reported that there are phytochemical constituents including isovanillic acid, mangiferin, protocatechuic acid, rutin, quercetin, and apigenin in this plant. However, the TPCs of aqueous and HEFEs in the present study are less than those in the flower extracts from B. malabaricum which is claimed to be a synonym of B. ceiba. This demonstrates that the flowers of B. malabaricum have remarkable antioxidant activity. In the present study, it was found that AFE and HEFE has higher inhibitory activity against DPPH and ABTS free radical than those of ALE and HELE. However, EFE has lower antioxidant activity than those of ELE. Due to the solvent's ability with different polarity, ethanol may be a suitable solvent for the extraction of polyphenol and less toxic to human health. ABTS scavenging activity of B. ceiba suggests that the phytochemicals within the extracts donate electron/hydrogen resulting in the reduction of oxidative stress. The reducing power of the extracts to reduce Fe+ is strong, and it depends on total phenolic and flavonoid contents. This result is similar to the previous study that flavonoid compound is secondary natural product metabolites responses for the antioxidant ability. In terms ofin vitro antidiabetic activities, B. ceiba flower extracts have higher α-glucosidase and α-amylase inhibitory activity than those of the standard acarbose. This suggests that the extracts are rich in flavonoids and phenolics which can inhibit α-glucosidase and α-amylase activity and potential to contribute to the management of diabetes. These results are similar to previous report that 50% ethanolic extract of stem bark and flowers of B. ceiba possesses hypoglycemic activity and mangiferin is responsible for the lowering of fasting blood glucose level.
| Conclusion|| |
The leaf and flower extracts of B. ceiba showed a significant antioxidant capacity against DPPH, ABTS+, and ferric-tripyridyltriazine radicals. The flower extracts exhibit high antioxidant and antidiabetic activities in vitro. These pharmacological potentials may be due to the presence of phenolic and flavonoid compound. These findings confirm the benefit of ethnobotanical uses of this plant.
The authors would like to acknowledge the Department of Biology, Faculty of Science, Mahasarakham University for laboratory equipment for completion of this research, and the Faculty of Medicine, Mahasarakham University, Thailand, for supporting facilities. This research was financially supported by the scholarship project of the promotion of science and mathematics talented teacher and Mahasarakham University (Grant year 2020).
Financial support and sponsorship
This research was financially supported by Faculty of Science, Mahasarakham University.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Jain V, Verma SK. Springer Briefs in Pharmacology and Toxicology. In: Pharmacology of Bombax ceiba
Linn. Heidelberg, New York, Dordrecht, London: Springer Science & Business Media; 2012. p. 12-45.
Meenakshi SC, Beldal BS, Londonkar RL. Review on ethnobotany phytoconstituents and phytopharmacology of Bombax ceiba
Linn. Int J Pharm Biol Sci 2019;9:1061-6.
Sharmin R, Islam MU, Joarder HH, Alamgir M, Mostofa G, Alam K. Antidiabetic and hepatoprotective activities of Bombax ceiba
young roots in alloxan-induced diabetic mice. J Nutrition Health Food Sci 2018;6:1-7.
Bhargava C, Thakur M, Yadav SK. Effect of Bombax ceiba
L. on spermatogenesis, sexual behaviour and erectile function in male rats. Andrologia 2012;44 Suppl 1:474-8.
Gupta P, Goyal R, Chauhan Y, Sharma PL. Possible modulation of FAS and PTP-1B signaling in ameliorative potential of Bombax ceiba
against high fat diet induced obesity. BMC Complement Altern Med 2013;13:281.
Singh A, Chauhan ES, Singh OP. Anti-hyperlipidaemic effect of Bombax ceiba
bark and seeds powder on albino wistar rats. World J Pharm Pharm Sci 2018;7:1259-76.
You YJ, Nam NH, Kim Y, Bae KH, Ahn BZ. Antiangiogenic activity of lupeol from Bombax ceiba
. Phytother Res 2003;17:341-4.
Bhavsar CJ, Talele GS. Potential anti-diabetic activity of Bombax ceiba
. Bangladesh J Pharm 2013;8:102-6.
Kumar A, Shamim S. Evaluation of wound healing activity of leaves of Bombax ceiba
. J Med Sci Clin Res 2018;6:119-26.
Xu GK, Qin XY, Wang GK, Xie GY, Li XS, Sun CY, et al
. Antihyperglycemic, antihyperlipidemic and antioxidant effects of standard ethanol extract of Bombax ceiba
leaves in high-fat-diet- and streptozotocin-induced Type 2 diabetic rats. Chin J Nat Med 2017;15:168-77.
Xu GK, Sun CY, Qin XY, Han Y, Li Y, Xie GY, et al
. Effects of ethanol extract of Bombax ceiba
leaves and its main constituent mangiferin on diabetic nephropathy in mice. Chin J Nat Med 2017;15:597-605.
Alsayari A, Ghazwani M, Almaghaslah D, Alhamhoom Y, Ahmed R, Saeed W, et al
. Bombax ceiba
: A potential anti-anxiety drug. Pharmacog J 2018;10:712-4.
Mostafa NM. β-Amyrin rich Bombax ceiba
leaf extract with potential neuroprotective activity against scopolamine-induced memory impairment in rats. Rec Nat Prod 2018;12:480-92.
Vieira TO, Said A, Aboutabl E, Azzam M, Creczynski-Pasa TB. Antioxidant activity of methanolic extract of Bombax ceiba
. Redox Rep 2009;14:41-6.
Nakashima S, Oda Y, Ogawa Y, Nakamura S, Uno M, Kishimoto M, et al
. Protective effects of compounds in Bombax ceiba
flower on benzo[a] pyrene-induced cytotoxicity. Nat Prod Commun 2018;13:561-4.
Wanjari MM, Gangoria R, Dey YN, Gaidhani SN, Pandey NK, Jadhav AD. Hepatoprotective and antioxidant activity of Bombax ceiba
flowers against carbon tetrachloride-induced hepatotoxicity in rats. Hepatoma Res 2016;2:144-50.
Patel SS, Verma NK, Rathore B, Nayak G, Singhai AK, Singh P. Cardioprotective effect of Bombax ceiba
flowers against acute adriamycin-induced myocardial infarction in rats. Rev Bras de Farmacognosia 2011;21:704-9.
Barakat MM, El-Boghdady NA, Farrag EK, Said AA, Shaker SE. Protective and curative effects of Bombax ceiba
flower and Ziziphus spina christi
fruit extracts on gastric ulcer. J Biol Sci 2019;19:161-72.
Tundis R, Rashed K, Said A, Menichini F, Loizzo MR.In vitro
cancer cell growth inhibition and antioxidant activity of Bombax ceiba
) flower extracts. Nat Prod Commun 2014;9:691-4.
Arafa AF, Foda DS, Mahmoud AH, Metwally NS, Farrag AR. Bombax ceiba
flowers extract ameliorates hepatosteatosis induced by ethanol and relatively moderate fat diet in rats. Toxicol Rep 2019;6:401-8.
Gadge NB, Jalalpure SS. Curative treatment with extracts of Bombax ceiba
fruit reduces risk of calcium oxalate urolithiasis in rats. Pharm Biol 2012;50:310-7.
Jalalpure SS, Gadge NB. Diuretic effects of young fruit extracts of Bombax ceiba
L. In rats. Indian J Pharm Sci 2011;73:306-11.
] [Full text]
Hossain E, Mandal SC, Gupta JK. Phytochemical screening andin vivo
antipyretic activity of the methanol leaf-extract of Bombax malabaricum
). Trop J Pharm Res 2011;10:55-60.
Yu YG, He QT, Yuan K, Xiao XL, Li XF, Liu DM, et al
antioxidant activity of Bombax malabaricum
flower extracts. Pharm Biol 2011;49:569-76.
El-Toumy SA, Hawas UW, Taie HA. Xanthones and antitumor activity of Bombax ceiba
against ehrlich ascites carcinoma cells in mice. Chem Nat Comp 2013;49:945-50.
Joshi KR, Devkota HP, Yahara S. Chemical analysis of flowers of Bombax ceiba
from Nepal. Nat Prod Commun 2013;8:583-4.
Depani P, Gadhvi K, Vyas S. Ethnobotanical potential and phytochemical screening of Bombax ceiba
L. Eur J Med Plants 2019;29:1-8.
Thongmee O, Rodhetbhai C, Siltragool W. Lanna food: The cultural management strategy for the creative economy development. Silpakorn Univ J Soc Sci Humanit Art 2015;15:105-19.
Wadood A, Ghufran M, Jamal SB, Naeem M, Khan A, Ghaffar R, et al.
Phytochemical analysis of medicinal plants occurring in local area of Mardan. Biochem Anal Biochem 2013;2:1-4.
Singleton VL, Orthofer R, Lamuela-Raventos RM. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Am J Enol 1999;299:152-78.
Zhishen J, Mengcheng T, Jianming W. The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem 1999;64:555-9.
Brand-Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate antioxidant activity. Lebensm-Wiss u-Technol 1995;28:25-30.
Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 1999;26:1231-7.
Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of ''antioxidant power'': The FRAP Assay. Analyt Biochem 1996;239:70-6.
Dong HQ, Li M, Zhu F, Liu FL, Huang JB. Inhibitory potential of trilobatin from Lithocarpus polystachyus
Rehd against α-glucosidase and α-amylase linked to type 2 diabetes. Food Chem 2012;130:261-6.
Akkarachaiyasit S. Alpha-amylase inhibitory activity and antihyperglycemic effects of cyaniding and its derivatives. Chulalongkorn University Thesis for Master of Science Degree in Pharmacology; 2008. p. 48-9.
Antil V, Sinha BN, Pandey A, Diwan A, Saini P. Bombax malabaricum
: A salutary boon. Int J Pharm Invest 2013;3:17-28.
Do QD, Angkawijaya AE, Tran-Nguyen PL, Huynh LH, Soetaredjo FE, Ismadji S, et al
. Effect of extraction solvent on total phenol content, total flavonoid content, and antioxidant activity of Limnophila aromatica
. J Food Drug Anal 2014;22:296-302.
Afsar T, Razak S, Khan MR, Mawash S, Almajwal A, Shabir M, et al
. Evaluation of antioxidant, anti-hemolytic and anticancer activity of various solvent extracts of Acacia hydaspica
R. Parker aerial parts. BMC Complement Altern Med 2016;16:258.
Prior RL, Cao GH, Martin A, Sofic E, McEwen J, O'Brien C, et al
. Antioxidant capacity as influenced by total phenolic and anthocyanin content, maturity and variety of Vaccinium
species. J Agric Food Chem 1998;46:2686-93.
Tadera K, Minami Y, Takamatsu K, Matsuoka T. Inhibition of alpha-glucosidase and alpha-amylase by flavonoids. J Nutr Sci Vitaminol (Tokyo) 2006;52:149-53.
Jain V, Verma SK. Assessment of credibility of some folk medicinal claims on Bombax ceiba
L. Indian J Trad Knowl 2014;13:87-94.
[Table 1], [Table 2], [Table 3], [Table 4]